Please provide your email address to receive an email when new articles are posted on . Researchers evaluated a blood test’s ability to predict recurrence in patients with stage 3 melanoma.

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows. Monitoring blood levels of DNA fragments shed by dying tumor cells ...

A group of researchers at the University of Michigan developed a two-line strip test and micro-needle patch to detect melanoma from home.

A simple blood test could reveal who is at high risk of skin cancer recurrence after tumor-removal surgery. The test can detect fragments of tumor DNA with a simple blood draw to reveal the lingering ...

FRIENDSWOOD, Texas, April 28, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its ...

A simple skin patch and COVID-like test could soon allow people to test for melanoma in the comfort of their home—helping catch the most dangerous type of skin cancer early without the need for a ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced the publication of a prospectively designed, ...

The newly designed ExoPatch being removed from a sample of mouse skin successfully distinguished melanoma from healthy skin in mice. Credit: Jeremy Little, Michigan Engineering An experimental patch ...

Leah Adams’ father had just had a melanoma lesion removed when her mother noticed an unusual mole on Leah’s chest. Less than a month later, during her first-ever skin check, Leah’s dermatologist ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows. Led by researchers at NYU Langone Health and its Perlmutter Cancer ...